RADX

0.63046.33%
NP

Noel P. Donnelly

Chief Financial Officer

Mr. Noel P. Donnelly, M.B.A., serves as Independent Non-Executive Director at Radiopharm Theranostics Limited since October 1, 2024. He serves as Chief Financial Officer at PepGen Inc. since October 2021. He has vast leadership experience in finance, strategy and operations within the biopharmaceutical and biotechnology industries. He has a distinguished track record of building and leading cross-functional teams, driving corporate governance and executing complex financial strategies that support rapid company growth. He served as the Chief Financial Officer of EIP Pharma, Inc. since July 8, 2019 until 2021. Mr. Donnelly joined EIP Pharma from Takeda Pharmaceuticals where he led a group focused on strategy and operations. From June 2004 until July 2019, Mr. Donnelly served in various roles of increasing seniority at Shire plc, a biopharmaceutical company, including Vice President, Research and Development Business Ops from 2004 to 2019; Senior Director, Head of Research and Development Business Analytics and Knowledge Management; Senior Director, Head of Research and Development Finance; Director, Financial Planning and Analysis; and Associate Director, Financial Planning and Analysis. Prior to that he worked in financial planning and analysis in financial services and industrial companies. He received his MBA with a Concentration in Finance from F. W. Olin Graduate School of Business at Babson College and his B.A. in Science in Nuclear Engineering with a Minor in Economics from the University of Massachusetts-Lowell.

Positions